These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23508884)

  • 1. Reply: To PMID 22886739.
    Simard JF; Neovius M; Askling J
    Arthritis Rheum; 2013 Jun; 65(6):1671-2. PubMed ID: 23508884
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality rates among patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: comment on the article by Simard et al.
    Moulis G; Sommet A; Lapeyre-Mestre M
    Arthritis Rheum; 2013 Jun; 65(6):1670-1. PubMed ID: 23508973
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoplasms as the leading cause of death among patients with rheumatoid arthritis receiving tumor necrosis factor inhibitors: comment on the article by Simard et al.
    Yazici H; Tascilar K; Yazici Y
    Arthritis Rheum; 2013 Jun; 65(6):1670. PubMed ID: 23508926
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: To PMID 25371395.
    Gregersen PK; Oswald M; Curran M; Carulli J;
    Arthritis Rheumatol; 2015 May; 67(8):2277. PubMed ID: 25989099
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular events in early rheumatoid arthritis--role of tumor necrosis factor inhibition.
    Ljung L
    J Rheumatol; 2014 Nov; 41(11):2094-6. PubMed ID: 25362704
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Okamoto H
    N Engl J Med; 2006 Nov; 355(19):2047; author reply 2048. PubMed ID: 17099950
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply: To PMID 22504829.
    Curtis JR
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1271-2. PubMed ID: 24757074
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals.
    Buch MH; Marzo-Ortega H; Bingham SJ; Emery P
    Rheumatology (Oxford); 2004 Feb; 43(2):243-4. PubMed ID: 14739466
    [No Abstract]   [Full Text] [Related]  

  • 10. Perioperative management of patients with rheumatoid arthritis treated with TNF-alpha blocking agents.
    Goupille P; Pham T; Sibilia J; Mariette X
    Semin Arthritis Rheum; 2007 Dec; 37(3):202-3; author reply 203. PubMed ID: 17570470
    [No Abstract]   [Full Text] [Related]  

  • 11. Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?
    Conaghan PG; Quinn MA; O'Connor P; Wakefield RJ; Karim Z; Emery P
    Arthritis Rheum; 2002 Jul; 46(7):1971-2; author reply 1973. PubMed ID: 12124886
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient preferences in choosing anti-TNF therapies-R1.
    Williams EL; Edwards CJ
    Rheumatology (Oxford); 2006 Dec; 45(12):1575-6. PubMed ID: 17085468
    [No Abstract]   [Full Text] [Related]  

  • 13. Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare?
    Aslanidis S; Pyrpasopoulou A; Douma S; Petidis K
    Arthritis Rheum; 2008 Jan; 58(1):327-8. PubMed ID: 18163500
    [No Abstract]   [Full Text] [Related]  

  • 14. [TNF-inhibitors slow down joint destruction in rheumatoid arthritis. No cure, but dramatic relief of symptoms].
    Wollheim FA
    Lakartidningen; 2001 May; 98(21):2560-2. PubMed ID: 11433990
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis.
    Gonzalez-Juanatey C; Llorca J; Garcia-Porrua C; Martin J; Gonzalez-Gay MA
    Arthritis Rheum; 2006 Feb; 55(1):150-3. PubMed ID: 16463428
    [No Abstract]   [Full Text] [Related]  

  • 16. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
    Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
    Dermatology; 2008; 217(4):380. PubMed ID: 18849606
    [No Abstract]   [Full Text] [Related]  

  • 17. [New therapies in rheumatoid arthritis. Stopping joint deterioration].
    Rautenstrauch J
    MMW Fortschr Med; 2000 Jan; 142(3):4-8. PubMed ID: 10726453
    [No Abstract]   [Full Text] [Related]  

  • 18. Blocking tumor necrosis factor inhibits radiographic damage even in patients who show minimal or no clinical improvement: comment on the concise communication by Boers.
    Lipsky PE; Felson DT; Maini RN
    Arthritis Rheum; 2002 Oct; 46(10):2817-8; author reply 2718-21. PubMed ID: 12384946
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination DMARD therapy for rheumatoid arthritis.
    Kremer JM
    Manag Care; 2001 Jul; 10(7 Suppl):10-4. PubMed ID: 11729428
    [No Abstract]   [Full Text] [Related]  

  • 20. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
    Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
    Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.